Mass chemotherapy options to control lymphatic filariasis: a systematic review.
Identifieur interne : 007F45 ( Main/Exploration ); précédent : 007F44; suivant : 007F46Mass chemotherapy options to control lymphatic filariasis: a systematic review.
Auteurs : Daniel J. Tisch [États-Unis] ; Edwin Michael ; James W. KazuraSource :
- The Lancet. Infectious diseases [ 1473-3099 ] ; 2005.
Descripteurs français
- KwdFr :
- MESH :
- pathogénicité : Wuchereria bancrofti.
- traitement médicamenteux : Filariose lymphatique.
- usage thérapeutique : Filaricides.
- Animaux, Association de médicaments, Essais contrôlés randomisés comme sujet, Humains, Résultat thérapeutique.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Filaricides.
- drug therapy : Elephantiasis, Filarial.
- pathogenicity : Wuchereria bancrofti.
- Animals, Drug Therapy, Combination, Humans, Randomized Controlled Trials as Topic, Treatment Outcome.
Abstract
Understanding the efficacy of microfilaricidal drugs is important in guiding the global programme for the elimination of lymphatic filariasis as a public-health problem. We did a systematic review of the available literature to determine which currently available drug intervention most effectively decreases circulating Wuchereria bancrofti microfilaria in individuals and populations. 57 randomised studies of drug efficacy were identified. Data were combined and compared using weighted mean effect estimates taking into account the longitudinal nature of the data. Combined treatment with diethylcarbamazine plus ivermectin, diethylcarbamazine plus albendazole, and ivermectin plus albendazole resulted in average microfilarial intensity decreases that were 0.7%, 4.6%, and 12.7% of the pre-treatment values, respectively. Drug combinations containing diethylcarbamazine were the most effective against microfilarial prevalence and intensity relative to single drugs or other combinations. The relative efficacies of drug combinations have not been well documented from existing studies and therefore limit the application of evidenced-based recommendations for chemotherapy-based interventions to control lymphatic filariasis. These results provide valuable estimates of drug effect using existing data, but highlight the need for more comprehensive comparative drug studies.
DOI: 10.1016/S1473-3099(05)70192-4
PubMed: 16048720
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003C33
- to stream PubMed, to step Curation: 003C33
- to stream PubMed, to step Checkpoint: 003C33
- to stream Ncbi, to step Merge: 001F09
- to stream Ncbi, to step Curation: 001F09
- to stream Ncbi, to step Checkpoint: 001F09
- to stream Main, to step Merge: 008155
- to stream Main, to step Curation: 007F45
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Mass chemotherapy options to control lymphatic filariasis: a systematic review.</title><author><name sortKey="Tisch, Daniel J" sort="Tisch, Daniel J" uniqKey="Tisch D" first="Daniel J" last="Tisch">Daniel J. Tisch</name><affiliation wicri:level="1"><nlm:affiliation>Department of Epidemiology and Biostatistics and Center for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio 44106-7286, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Epidemiology and Biostatistics and Center for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio 44106-7286</wicri:regionArea><wicri:noRegion>Ohio 44106-7286</wicri:noRegion></affiliation></author><author><name sortKey="Michael, Edwin" sort="Michael, Edwin" uniqKey="Michael E" first="Edwin" last="Michael">Edwin Michael</name></author><author><name sortKey="Kazura, James W" sort="Kazura, James W" uniqKey="Kazura J" first="James W" last="Kazura">James W. Kazura</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:16048720</idno><idno type="pmid">16048720</idno><idno type="doi">10.1016/S1473-3099(05)70192-4</idno><idno type="wicri:Area/PubMed/Corpus">003C33</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003C33</idno><idno type="wicri:Area/PubMed/Curation">003C33</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003C33</idno><idno type="wicri:Area/PubMed/Checkpoint">003C33</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003C33</idno><idno type="wicri:Area/Ncbi/Merge">001F09</idno><idno type="wicri:Area/Ncbi/Curation">001F09</idno><idno type="wicri:Area/Ncbi/Checkpoint">001F09</idno><idno type="wicri:doubleKey">1473-3099:2005:Tisch D:mass:chemotherapy:options</idno><idno type="wicri:Area/Main/Merge">008155</idno><idno type="wicri:Area/Main/Curation">007F45</idno><idno type="wicri:Area/Main/Exploration">007F45</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Mass chemotherapy options to control lymphatic filariasis: a systematic review.</title><author><name sortKey="Tisch, Daniel J" sort="Tisch, Daniel J" uniqKey="Tisch D" first="Daniel J" last="Tisch">Daniel J. Tisch</name><affiliation wicri:level="1"><nlm:affiliation>Department of Epidemiology and Biostatistics and Center for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio 44106-7286, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Epidemiology and Biostatistics and Center for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio 44106-7286</wicri:regionArea><wicri:noRegion>Ohio 44106-7286</wicri:noRegion></affiliation></author><author><name sortKey="Michael, Edwin" sort="Michael, Edwin" uniqKey="Michael E" first="Edwin" last="Michael">Edwin Michael</name></author><author><name sortKey="Kazura, James W" sort="Kazura, James W" uniqKey="Kazura J" first="James W" last="Kazura">James W. Kazura</name></author></analytic><series><title level="j">The Lancet. Infectious diseases</title><idno type="ISSN">1473-3099</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Drug Therapy, Combination</term><term>Elephantiasis, Filarial (drug therapy)</term><term>Filaricides (therapeutic use)</term><term>Humans</term><term>Randomized Controlled Trials as Topic</term><term>Treatment Outcome</term><term>Wuchereria bancrofti (pathogenicity)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Association de médicaments</term><term>Essais contrôlés randomisés comme sujet</term><term>Filaricides (usage thérapeutique)</term><term>Filariose lymphatique (traitement médicamenteux)</term><term>Humains</term><term>Résultat thérapeutique</term><term>Wuchereria bancrofti (pathogénicité)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Filaricides</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Filaricides</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Drug Therapy, Combination</term><term>Humans</term><term>Randomized Controlled Trials as Topic</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Association de médicaments</term><term>Essais contrôlés randomisés comme sujet</term><term>Humains</term><term>Résultat thérapeutique</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Understanding the efficacy of microfilaricidal drugs is important in guiding the global programme for the elimination of lymphatic filariasis as a public-health problem. We did a systematic review of the available literature to determine which currently available drug intervention most effectively decreases circulating Wuchereria bancrofti microfilaria in individuals and populations. 57 randomised studies of drug efficacy were identified. Data were combined and compared using weighted mean effect estimates taking into account the longitudinal nature of the data. Combined treatment with diethylcarbamazine plus ivermectin, diethylcarbamazine plus albendazole, and ivermectin plus albendazole resulted in average microfilarial intensity decreases that were 0.7%, 4.6%, and 12.7% of the pre-treatment values, respectively. Drug combinations containing diethylcarbamazine were the most effective against microfilarial prevalence and intensity relative to single drugs or other combinations. The relative efficacies of drug combinations have not been well documented from existing studies and therefore limit the application of evidenced-based recommendations for chemotherapy-based interventions to control lymphatic filariasis. These results provide valuable estimates of drug effect using existing data, but highlight the need for more comprehensive comparative drug studies.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country></list><tree><noCountry><name sortKey="Kazura, James W" sort="Kazura, James W" uniqKey="Kazura J" first="James W" last="Kazura">James W. Kazura</name><name sortKey="Michael, Edwin" sort="Michael, Edwin" uniqKey="Michael E" first="Edwin" last="Michael">Edwin Michael</name></noCountry><country name="États-Unis"><noRegion><name sortKey="Tisch, Daniel J" sort="Tisch, Daniel J" uniqKey="Tisch D" first="Daniel J" last="Tisch">Daniel J. Tisch</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 007F45 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 007F45 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:16048720
|texte= Mass chemotherapy options to control lymphatic filariasis: a systematic review.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:16048720" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |